WORKSHOPS
SUNDAY, APRIL 26, 2020

  815WORKSHOP I

CARDIOPULMONARY TRANSITION, POSTNATAL STABILIZATION
AND EMERGENCIES

Chair: O.D. Saugstad, Oslo, Norway; D. Singer, Hamburg, Germany

• Monitoring stabilization/resuscitation at birth
   A.B. te Pas, Leiden, The Netherlands

• Emergencies in the delivery room: When cardio-pulmonary transition fails
   C.C. Röhr, Oxford, UK

• Neonatal resuscitation guidelines: Scientific rationale and evidence
   O.D. Saugstad, Oslo, Norway

  945Interactive Discussion


1015
Coffee Break


1045
WORKSHOP II

RDS AND SURFACTANT
Chair: H.L. Halliday, Belfast, UK; H. Verder, Holbæk, Denmark

• A stepwise therapeutic approach to RDS
   P. Rimensberger, Geneva, Switzerland

• Strategies for optimizing non-invasive ventilation and surfactant application
   R. Ramanathan, Los Angeles, USA

• European guidelines for the management of RDS: Update 2020
   D.G. Sweet, Belfast, UK

1215Interactive Discussion


1245
Lunch


1315
Poster Session___


1415
WORKSHOP III

RESPIRATORY CARE IN DEVELOPING COUNTRIES
Chair: S. Lusyati, Jakarta, Indonesia; J. Smith, Tygerberg, South-Africa

• Optimal ventilation and surfactant in resource limited countries
   J. Smith, Tygerberg, South-Africa

• Neonatal respiratory failure: Problems and solutions: Chinese experience
   B. Sun, Shanghai, China

• Challenges in neonatal care in resource poor settings
   J. Haddad, Beirut, Lebanon

1545Interactive Discussion


1615
Coffee Break


1645
WORKSHOP IV

OPTIMAL VENTILATORY STRATEGIES
Chair: C. Bührer, Berlin, Germany; B. Sun, Shanghai, China

• Lung protective ventilation: Concepts and strategies
   A.H. van Kaam, Amsterdam, The Netherlands

• iNo for preterm infants: Evidence versus practice
   B. Thébaud, Ottawa, Canada

• HFOV in neonates: Still relevant in 2020?
   P. Rimensberger, Geneva, Switzerland

1815Interactive Discussion


 1900
Seminars___

     How to get your manuscript rejected?
         E.S. Shinwell, Tsfat, Israel

     How to design a clinical trial: From basics to pitfalls
         N. Modi, London, UK

     Neonatal clinical pharmacology:
         A delicate combination of developmental biology and genetics
         J.N. van den Anker, Washington D.C., USA


 2000
Adjourn


WORKSHOPS
SUNDAY, APRIL 26, 2020

Parallel Sessions

  815WORKSHOP V

INTRAUTERINE INFLAMMATION AND INFECTION
Chair: S. Andersson, Helsinki, Finland; E. Özek, Istanbul, Turkey

• Intrauterine inflammation and possible consequences for the preterm infant
   B.W. Kramer, Maastricht, The Netherlands

• Ureaplasma species: The hidden danger for preterm infants
   K. Glaser, Würzburg, Germany

• Intrauterine infection, prematurity and neonatal sepsis:
   Strategies for diagnosis and prevention
   R.A. Polin, New York, USA

   945Interactive Discussion


1015
Coffee Break


1045
WORKSHOP VI

THE NEONATAL IMMUNE SYSTEM AND IMMUNODEFICIENCIES
Chair: R. Carr, London, UK; B.W. Kramer, Maastricht, The Netherlands

• The immune system of the newborn
   G.A. Holländer, Oxford, UK

• When mother’s antibodies attack the neonate
   C. Bührer, Berlin, Germany

• Rare but dangerous: Immunodeficiencies of the newborn
   H. Morbach, Würzburg, Germany

1215Interactive Discussion


1245
Lunch


1315
Poster Session___


1415
WORKSHOP VII

STRATEGIES FOR A SUCCESSFUL FEEDING
Chair: I. Iskander, Cairo, Egypt; A. Liubsys, Vilnius, Lithuania

• Parenteral nutrition for immature preterm infants in the first week of life and beyond:
   Fluid intake, electrolytes and energy supply
   J. Bhatia, Augusta, USA

• Do we need fortifiers and nutritional supplements for preterm infants?
   N. Modi, London, UK

• Strategies for a successful feeding of the premature baby
   W.W. Hay Jr., Aurora, USA

1545Interactive Discussion


1615
Coffee Break


1645
WORKSHOP VIII

PAIN, SEIZURES AND ROP
Chair: N. Marlow, London, UK; J.M. Solano, Bogota, Colombia

• Is there a way to measure pain perception in preterm infants?
   R. Slater, Oxford, UK

• The role of aEEg in seizure identification and prediction of outcome
   L.S. de Vries, Utrecht, The Netherlands

• Growth factors and Anti-VEGF in severe ROP: Has the time come?
   A. Hellström, Gothenburg, Sweden

 1815Interactive Discussion


 1900
Seminars___

     How to get your manuscript rejected?
         E.S. Shinwell, Tsfat, Israel

     How to design a clinical trial: From basics to pitfalls
         N. Modi, London, UK

     Neonatal clinical pharmacology:
         A delicate combination of developmental biology and genetics
         J.N. van den Anker, Washington D.C., USA


 2000
Adjourn